T. Rowe Price Associates

Activity from announced rounds

Activity in this selectionavenue-capital-group-42018d56
Rounds participated in
10
Confirmed lead rounds
—
10 roles undisclosed
New companies
9
First participation on record · 1 follow-on
Funding in participating rounds
$4.4B
9 disclosed · full round size, not this investor’s share

By stage

Series C+7
Undisclosed2
Series A1

By primary sector

Biotech3
Defense tech2
AI1
Climate tech1
Developer tools1
2 more
Industrial tech1
Space tech1

By country

United States8
Australia1
Canada1

Rounds

10 in this selection
Cyclic Materials

Cyclic Materials recovers and produces rare earth materials through recycling.

$75MStrategic
Role not disclosed
Castelion

Builds low-cost, mass-producible hypersonic strike missiles for defense

$1BSeries C
Role not disclosed
Hadrian

Builds highly automated factories producing defense and aerospace systems

$1.4BSeries D
Role not disclosed
K2 Space

Manufacturer of big, high-power satellites

$500MSeries D
Role not disclosed
AdvanCell

Develops lead-212 targeted alpha therapies to treat cancer

$315MSeries D
Role not disclosed
SambaNova

Provides next-generation AI infrastructure for enterprises, neo-clouds, and sovereign AI initiatives

$350MSeries E
Role not disclosed
Third Arc Bio

Develops novel multifunctional antibodies for oncology and immunology & inflammation indications

$52MSeries A+
Role not disclosed
ClickHouse

Provides real-time analytics, data warehousing, observability, and AI/ML infrastructure

$400MSeries D
Role not disclosed
Hadrian

Builds highly automated factories producing defense and aerospace systems

UndisclosedUndisclosed
Role not disclosed
Parabilis Medicines

Develops medicines targeting historically undruggable protein targets in cancer

$305MSeries F
Role not disclosed